Cancers, Vol. 12, Pages 1278: Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors
Cancers, Vol. 12, Pages 1278: Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors
Cancers doi: 10.3390/cancers12051278
Authors:
Kasun Wanigasooriya
Robert Tyler
Joao D. Barros-Silva
Yashashwi Sinha
Tariq Ismail
Andrew D. Beggs
Radiotherapy is routinely used as a neoadjuvant, adjuvant or palliative treatment in various cancers. There is significant variation in clinical response to radiotherapy with or without traditional chemotherapy. Patients with a good response to radiotherapy demonstrate better clinical outcomes universally across different cancers. The PI3K/AKT/mTOR pathway upregulation has been linked to radiotherapy resistance. We reviewed the current literature exploring the role of inhibiting targets along this pathway, in enhancing radiotherapy response. We identified several studies using in vitro cancer cell lines, in vivo tumour xenografts and a few Phase I/II clinical trials. Most of the current evidence in this area comes from glioblastoma multiforme, non-small cell lung cancer, head and neck cancer, colorectal cancer, and prostate cancer. The biological basis for radiosensitivity following pathway inhibition was through inhibited DNA double strand break repair, inhibited cell proliferation, enhanced apoptosis and autophagy as well as tumour microenvironment changes. Dual PI3K/mTOR inhibition consistently demonstrated radiosensitisation of all types of ca...
Source: Cancers - Category: Cancer & Oncology Authors: Kasun Wanigasooriya Robert Tyler Joao D. Barros-Silva Yashashwi Sinha Tariq Ismail Andrew D. Beggs Tags: Review Source Type: research
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Colorectal Cancer | Gastroschisis Repair | Head and Neck Cancer | Lung Cancer | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Neurology | Non-Small Cell Lung Cancer | Palliative | Prostate Cancer | Rectal Cancers | Study